29 Sep 2023
A study presented at the European Association for the Study of Diabetes Annual Meeting has found that the weight loss drug Tirzepatide is more effective than Semaglutide in improving HbA1c and reducing weight in patients with type 2 diabetes.
Study using twins sees cardiovascular improvements with vegan diet
07 Dec 2023
Menarche at early age linked to increased diabetes risk
07 Dec 2023
In utero exposure to Covid-19 associated with preterm birth
07 Dec 2023
Type 2 diabetes risk may be reduced with fast walking
01 Dec 2023
Pomegranate consumption linked to prevention of metabolic disorders
01 Dec 2023